Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) from a hold rating to a buy rating in a report issued on Thursday.

A number of other equities research analysts have also recently issued reports on the company. Kepler Capital Markets raised Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research report on Wednesday, June 11th. Hsbc Global Res raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, June 11th. Finally, The Goldman Sachs Group raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 5th. One analyst has rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy”.

Bayer Aktiengesellschaft Trading Up 0.1%

Shares of OTCMKTS BAYRY opened at $7.67 on Thursday. The stock has a market cap of $30.14 billion, a price-to-earnings ratio of -8.34 and a beta of 0.85. The business has a 50 day simple moving average of $7.02 and a 200 day simple moving average of $6.12. Bayer Aktiengesellschaft has a 52 week low of $4.79 and a 52 week high of $8.58. The company has a debt-to-equity ratio of 1.07, a quick ratio of 0.79 and a current ratio of 1.25.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.63 by $0.02. The business had revenue of $15.27 billion during the quarter, compared to analysts’ expectations of $13.39 billion. Bayer Aktiengesellschaft had a positive return on equity of 13.94% and a negative net margin of 7.26%. On average, research analysts predict that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Increases Dividend

The firm also recently disclosed a dividend, which was paid on Monday, May 12th. Stockholders of record on Wednesday, April 30th were given a $0.0224 dividend. This represents a dividend yield of 0.38%. This is a boost from Bayer Aktiengesellschaft’s previous dividend of $0.02. The ex-dividend date was Tuesday, April 29th. Bayer Aktiengesellschaft’s dividend payout ratio is currently -2.17%.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.